gimli
SUDEEPPHRM stock analysis context
SUDEEP PHARMA Stock Context for AI Screening
SUDEEP PHARMA LIMITED is a small-cap stock in Chemicals. This page summarizes key screening signals for SUDEEP PHARMA, including recent returns, momentum indicators, valuation ratios, liquidity, and growth metrics. Gimli uses this context to help users ask natural-language stock screening questions across Indian equities.
Open interactive SUDEEPPHRM stock pagePrice
₹764.60
1W return
+9.68%
1M return
+8.06%
3M return
+28.18%
6M return
+12.25%
1Y return
n/a
Market cap
₹8,636.05 cr
PE
57.14
PB
12.45
ROE
n/a
ROCE
n/a
RSI
68.13
Turnover
₹18.18 cr
Why it can matter in screens
- Momentum: SUDEEPPHRM is above 50DMA; RSI is 68.13.
- Returns: 1D -1.58%, 1W +9.68%, 1M +8.06%, 3M +28.18%, 1Y n/a.
- Trend levels: 52W high ₹780.50, 52W low ₹530.00, off high -2.04%.
- Liquidity: latest turnover is ₹18.18 cr; volume vs 20D is +0.85%.
- Valuation/profitability: PE 57.14, PB 12.45, ROE n/a, ROCE n/a.
- Growth: 3Y sales CAGR n/a, 3Y profit CAGR n/a.
Financials and Ownership
Quarterly income statement
| Period | Revenue | EBITDA | PAT | EPS |
|---|---|---|---|---|
| 2025-12-31 | 172.34 cr | 66.81 cr | 47.46 cr | 4.29 |
| 2025-06-30 | 124.19 cr | 48.53 cr | 30.81 cr | 2.73 |
| 2025-03-31 | 152.96 cr | 61.35 cr | 44.15 cr | nan |
| 2024-12-31 | 115.54 cr | 41.73 cr | 28.71 cr | 2.54 |
Annual income statement
No recent data available.
Balance sheet
| Period | Assets | Cash | Debt | Equity |
|---|---|---|---|---|
| 2025-06-30 | 922.26 cr | 42.67 cr | 138.08 cr | 693.93 cr |
| 2025-03-31 | 717.17 cr | 36.81 cr | 137.55 cr | 493.09 cr |
Cash flow
| Period | OCF | FCF | Cash change |
|---|---|---|---|
| 2025-12-31 | n/a | n/a | n/a |
| 2025-06-30 | -5.48 cr | -20.00 cr | n/a |
| 2025-03-31 | n/a | n/a | n/a |
| 2024-12-31 | n/a | n/a | n/a |
Shareholding Trend
| Period | Promoter | FII/FPI | DII | MF | Retail | Pledge |
|---|---|---|---|---|---|---|
| 2026-03-31 | +76.15% | +1.55% | +18.11% | +6.19% | +4.18% | +100.00% |
| 2025-12-31 | +76.15% | +1.67% | +17.60% | +5.67% | +4.58% | +100.00% |
| 2025-11-27 | +76.15% | +1.54% | +14.76% | +3.44% | +7.54% | +100.00% |
Industry Peers
| Symbol | Name | Mcap | PE | ROE | 1Y |
|---|---|---|---|---|---|
| SOLARINDS | SOLAR INDUSTRIES (I) LTD | 168,103.46 cr | 100.207719 | +42.13% | +11.78% |
| PIDILITIND | PIDILITE INDUSTRIES LTD | 149,531.55 cr | 65.239786 | +24.68% | -5.09% |
| SRF | SRF LTD | 80,575.01 cr | 40.837586 | +16.37% | -7.99% |
| LINDEINDIA | LINDE INDIA LIMITED | 60,641.33 cr | 113.297456 | +14.69% | -4.83% |
| FACT | FACT LTD | 56,385.85 cr | 3734.162522 | +1.11% | -16.76% |
| UPL | UPL LIMITED | 54,537.56 cr | 24.078392 | +6.42% | +1.68% |
| COROMANDEL | COROMANDEL INTERNTL. LTD | 51,446.03 cr | 29.729167 | +16.74% | -24.59% |
| PIIND | PI INDUSTRIES LTD | 41,540.89 cr | 31.451308 | +13.99% | -28.17% |
Try these prompts
- Analyze SUDEEP PHARMA with valuation, momentum and industry peers
- Compare SUDEEPPHRM with other Chemicals stocks
- Show small-cap stocks in Chemicals above 50DMA with positive 1M return
- Find Chemicals stocks with improving momentum and reasonable valuation
Related screen ideas
- View Chemicals stocks
- View small-cap stocks
- Find stocks above 50DMA
- Compare SUDEEPPHRM with other Chemicals stocks
Data snapshot: 2026-06-03. Not investment advice.